Draganfly (DFLY.C) teamed up with Coldchain Technology Services by selling four Vital Intelligence assessment units to use with its customer base today, according to a press release.

Coldchain provides healthcare supply chain management solutions for multiple government and commercial clients, including the United States Army, the Centers for Disease Control (CDC), Reserve Component Forces, Johnson & Johnson brands and the Chicago Department of Public Health among others.

“The partnership between CTS and Draganfly will enable real-time vital screening to our customer base. Their technology is a value-add to the current rapid response COVID-19 tests we offer in addition to the telehealth services we offer. Draganfly’s commitment to providing the best, most secure and accurate vital signs screening available makes them the perfect partner for our organization,” said Wayne Williams founder and executive director of Coldchain Technology.

CT’s contribution to fighting COVID-19 has been detection tests that provide positive results in five minutes and negative rules in 13, rolled out in early days of the pandemic.

Draganfly’s Vital Intelligence screening technology is quick and contactless, and therefore non-invasive. In seconds they can detect elevated body temperature and with consent they can collect heart rate, respiratory rate and O2 saturation, all from a camera. The platform comes with an API for third party developers to integrate the tech with their own apps and devices.

“We worked with CTS when we installed 5 of our vital assessment technology units and distancing stations at Alabama State University as part of the “Safely Open Schools Solution. We are incredibly excited to be further partnering and working with their team in an expanded role to deliver our Vital Intelligence technology,” said Cameron Chell, CEO of Draganfly.

The purchase by CTS is for USD$25,000 each and are being scheduled for immediate delivery.

—Joseph Morton